2021-04-09

Få omedelbar tillgång till ett gratis live streamade Acasti Pharma Inc diagram.

The average Acasti Pharma stock price prediction forecasts a potential downside of N/A from the current ACST share price of $0.54. Acasti Pharma Inc. ("Acasti or the "Company") (NASDAQ: ACST - TSX-V: ACST) today announced its operating and financial results for the third quarter of fiscal 2021 ended December 31, 2020. The all-time high Acasti Pharma stock closing price was 40.70 on August 05, 2013. The Acasti Pharma 52-week high stock price is 1.22, which is 114% above the current share price.

Acasti pharma stock

The stock's last reported lowest price was 0.52. Equity ratings for Acasti Pharma are calculated daily based on our scoring framework.The performance scores are derived for the period starting the 9th of January 2021 and ending today, the 9th of April 2021 Promoted When trading Acasti Pharma or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Acasti Pharma Inc - Class A () Stock Market info Recommendations: Buy or sell Acasti Pharma Inc - Class A stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Acasti Pharma Inc - Class A share forecasts, stock quote and buy / sell signals below.According to present data Acasti Pharma Inc - Class A's ACST shares and potentially its market environment have Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the… 2021-01-21 Technical Analysis Summary for Acasti Pharma with Moving Average, Stochastics, MACD, RSI, Stock Market Ideas. 5G Stocks Biotechnology Stocks Blockchain Stocks Bullish Moving Averages Candlestick Patterns Cannabis Stocks Dividend Stocks eMACD Buy Signals EV Stocks Gold Stocks Hot Penny Stocks Oil Stocks SPAC Stocks Top Stocks Under $10.

Promoted When trading Acasti Pharma or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account.

Acasti Pharma Inc. … 2021-01-05 On average, Wall Street analysts predict that . Acasti Pharma's share price could stay at $0.92 by Sep 2, 2021. The average Acasti Pharma stock price prediction forecasts a potential downside of N/A from the current ACST share price of $0.54. Acasti Pharma Inc. is a biopharmaceutical company.

1 Sep 2020 Shares of Acasti plummeted on Monday as CaPre was found to have missed its primary endpoint, which was observation of a statistically

Acasti Pharma Earnings Estimates and Actuals by Quarter 2021-01-22 · Shares of Acasti Pharma spiked to a 52 week high of $1.09 during the early Thursday trading sessions. 216 Million shares of Acasti Pharma was traded today compared to the average volume of 35 Million. Meanwhile, Acasti Pharma initiates a review process to evaluate strategic alternatives to boost shareholder value. I dag · Acasti Pharma Inc. (NASDAQ:ACST) went down by -5.35% from its latest closing price compared to the recent 1-year high of $1.22.
Lundaman skrivare

Monday’s close was ACST’s lowest close since 2018.

2021-03-15 · To see how Acasti Pharma Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: ACST stock’s performance was +4.32% in the latest trading, and +126.25% in the past year, while Bausch Health Companies Inc (BHC) has traded -3.03% on the day and positioned +105.55% higher than it was a year ago. Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the U.S. population.
Metrostation vd madeweg

ValuEngine. A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable

I dag · Acasti Pharma Inc. (NASDAQ:ACST) went down by -5.35% from its latest closing price compared to the recent 1-year high of $1.22. The company’s stock price has collected -13.56% of loss in the last five trading sessions.

Gratis parkering karlstad

2021-03-28 · Acasti Pharma's stock was trading at $0.3849 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ACST shares have increased by 40.0% and is now trading at $0.5388.

2.30 ACSTAcasti Pharma Inc. 0.43.

Find the latest Acasti Pharma, Inc. (ACST) stock quote, history, news and other vital information to help you with your stock trading and investing.

1 dag sedan · Acasti Pharma Inc. has a market cap of $107.82 Million and is expected to release its quarterly earnings report on February 09, 2021. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the ACST stock to lose ahead of the earnings release. Acasti Pharma has generated ($0.23) earnings per share over the last year. Acasti Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 5th, 2021 based off prior year's report dates. Acasti Pharma Earnings Estimates and Actuals by Quarter 2021-01-22 · Shares of Acasti Pharma spiked to a 52 week high of $1.09 during the early Thursday trading sessions. 216 Million shares of Acasti Pharma was traded today compared to the average volume of 35 Million. Meanwhile, Acasti Pharma initiates a review process to evaluate strategic alternatives to boost shareholder value.

View which stocks have been most impacted by COVID-19. What price target have analysts set for ACST?